Biosimilars Forum Urges Equal Access For US Humira Rivals

Executive Director Julie Reed Calls For Availability As Adalimumab Biosimilars Launch

 
• By Dave Wallace

With the US on the cusp of biosimilar competition to Humira, Julie Reed – executive director of the country’s Biosimilars Forum – has urged PBMs to bolster access by making all adalimumab biosimilars available as they launch throughout 2023.

Opportunity Equity Access Jigsaw Puzzle Pieces
The US needs access to all adalimumab biosimilars, Julie Reed believes • Source: Shutterstock

More from Biosimilars

More from Products